BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 17625305)

  • 1. Action of antiproteases on the inflammatory response in acute pancreatitis.
    Chen CC; Wang SS; Lee FY
    JOP; 2007 Jul; 8(4 Suppl):488-94. PubMed ID: 17625305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis.
    Chen CC; Wang SS; Tsay SH; Lee FY; Lu RH; Chang FY; Lee SD
    Cytokine; 2006 Jan; 33(2):95-9. PubMed ID: 16473521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic antiproteases in acute pancreatitis: an experimental study.
    Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
    Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreas: healing response in critical illness.
    Bentrem DJ; Joehl RJ
    Crit Care Med; 2003 Aug; 31(8 Suppl):S582-9. PubMed ID: 12907888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
    Freise J; Melzer P; Schmidt FW; Horbach L
    Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
    Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
    G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum interleukin-6 and interleukin-10 in patients with acute pancreatitis: clinical implications.
    Ohmoto K; Yamamoto S
    Hepatogastroenterology; 2005; 52(64):990-4. PubMed ID: 16001614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
    Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
    Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproteases in the treatment of acute necrotizing pancreatitis: continuous regional arterial infusion.
    Takeda K
    JOP; 2007 Jul; 8(4 Suppl):526-32. PubMed ID: 17625310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effects of human urinary trypsin inhibitor on acute experimental pancreatitis].
    Ohnishi H; Kosuzume H; Ashida Y; Kato K; Suzuki Y; Honjo I
    Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):235-44. PubMed ID: 6345304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents.
    Ishikura H; Nishimura S; Matsunami M; Tsujiuchi T; Ishiki T; Sekiguchi F; Naruse M; Nakatani T; Kamanaka Y; Kawabata A
    Life Sci; 2007 May; 80(21):1999-2004. PubMed ID: 17433371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cytokine strategies in acute pancreatitis: pathophysiological insights and clinical implications.
    Rau BM; Krüger CM; Schilling MK
    Rocz Akad Med Bialymst; 2005; 50():106-15. PubMed ID: 16358948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inflammatory cascade in acute pancreatitis: relevance to clinical disease.
    Elfar M; Gaber LW; Sabek O; Fischer CP; Gaber AO
    Surg Clin North Am; 2007 Dec; 87(6):1325-40, vii. PubMed ID: 18053834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction.
    Chen HM; Chen JC; Hwang TL; Jan YY; Chen MF
    Hepatogastroenterology; 2000; 47(34):1147-50. PubMed ID: 11020900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mediators in acute pancreatitis.
    Bhatia M; Brady M; Shokuhi S; Christmas S; Neoptolemos JP; Slavin J
    J Pathol; 2000 Feb; 190(2):117-25. PubMed ID: 10657008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and treatment of acute pancreatitis: new therapeutic targets--a ray of hope?
    Felderbauer P; Müller C; Bulut K; Belyaev O; Schmitz F; Uhl W; Schmidt WE
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):342-50. PubMed ID: 16364048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concept of SIRS and severe acute pancreatitis].
    Hirota M; Sugita H; Maeda K; Ichibara A; Ogawa M
    Nihon Rinsho; 2004 Nov; 62(11):2128-36. PubMed ID: 15552899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of inflammatory cells in pancreatitis.
    Mayerle J; Dummer A; Sendler M; Malla SR; van den Brandt C; Teller S; Aghdassi A; Nitsche C; Lerch MM
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():47-51. PubMed ID: 22320916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the liver in systemic complications associated with acute pancreatitis: the role of Kupffer cells.
    Folch-Puy E
    J Pathol; 2007 Mar; 211(4):383-8. PubMed ID: 17212343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mediators and cytokines--new aspects of the pathophysiology and assessment of severity of acute pancreatitis?
    Gross V; Leser HG; Heinisch A; Schölmerich J
    Hepatogastroenterology; 1993 Dec; 40(6):522-30. PubMed ID: 7509768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.